EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ebselen Suppresses Breast Cancer Tumorigenesis by Inhibiting YTHDF1-Mediated c-Fos Expression

Arathy Vasukutty iD, Poshan Yugal Bhattarai, Hong Seok Choi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Arathy Vasukutty und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Organoselenium Compounds, Azoles, Proto-Oncogene Proteins c-fos. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chosun University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

YTHDF1, an N6-methyladenosine (m6A)-binding protein, plays a key role in breast cancer progression, yet its therapeutic targeting remains underexplored. In this study, we investigated the anticancer effects of the novel YTHDF1 inhibitor ebselen in breast cancer cells. Ebselen treatment reduced cell viability in a dose-dependent manner and induced apoptosis, as demonstrated by Annexin V staining, Sub-G1 accumulation, and DNA fragmentation. Consistently, ebselen increased reactive oxygen species (ROS) production and impaired autophagy induction. Mechanistically, ebselen impaired YTHDF1-mediated stabilization and translation of FOS mRNA, leading to decreased c-Fos expression. In addition, ebselen suppressed anchorage-independent growth in vitro and significantly reduced tumor growth in an orthotopic mouse model. These findings highlight YTHDF1 as a promising therapeutic target and support ebselen as a potential small-molecule inhibitor for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsOrganoselenium CompoundsAzolesProto-Oncogene Proteins c-fosGene Expression Regulation, NeoplasticRNA-Binding ProteinsCarcinogenesisIsoindolesHumansFemaleAnimalsMiceCell Line, TumorApoptosisReactive Oxygen SpeciesCell ProliferationCell SurvivalXenograft Model Antitumor AssaysAutophagy

Stichwörter der Autor:innen

YTHDF1breast tumorigenesisc-Fos proto-oncogeneebselenm6A reader

Substanzen

ebselenIsoindolesOrganoselenium CompoundsAzolesProto-Oncogene Proteins c-fosReactive Oxygen SpeciesRNA-Binding Proteins

Autor:innen und Institutionen

  • Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.

ORCID-Profile: Arathy Vasukutty, Hong Seok Choi

Förderung

  • Chosun University

Zitieren

APA

Vasukutty, A., Bhattarai, P. Y., & Choi, H. S. (2025). Ebselen Suppresses Breast Cancer Tumorigenesis by Inhibiting YTHDF1-Mediated c-Fos Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199416

Vancouver

Vasukutty A, Bhattarai PY, Choi HS. Ebselen Suppresses Breast Cancer Tumorigenesis by Inhibiting YTHDF1-Mediated c-Fos Expression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199416

BibTeX
@article{Vasukutty2025,
  author = {Vasukutty, Arathy and Bhattarai, Poshan Yugal and Choi, Hong Seok},
  title = {Ebselen Suppresses Breast Cancer Tumorigenesis by Inhibiting YTHDF1-Mediated c-Fos Expression},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199416}
}
Kostenlos starten →